AZEDRA
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Oct 2012)
What this means for you
This application is over — abandoned 15 Oct 2012. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77923215
- Mark type
- Stylized text
- Filed
- 29 Jan 2010
- Published for opposition
- 15 Jun 2010
- Abandoned
- 15 Oct 2012
- Attorney of record
- Phi Lan Tinsley
Goods and services
- Class 005 — Pharmaceuticals: Radiopharmaceutical compositions for treating neuro-endocrine cancers
Owner
- Molecular Insight Pharmaceuticals, Inc., Cambridge, MA, US
- Molecular Insight Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 23 Jan 2013 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 15 Oct 2012 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 15 Oct 2012 — ABANDONMENT - NO USE STATEMENT FILED
- 02 Oct 2012 — CORRECTED NOA MAILED
- 29 Sept 2012 — CORRECTED NOA E-MAILED
- 28 Sept 2012 — NOTICE OF ALLOWANCE CORRECTION ENTERED
- 25 Sept 2012 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Sept 2012 — PAPER RECEIVED
- 25 Sept 2012 — OPPOSITION TERMINATED NO. 999999
- 25 Sept 2012 — OPPOSITION DISMISSED NO. 999999
- 13 Mar 2012 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Feb 2012 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Feb 2012 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 31 Jan 2012 — TTAB RELEASE CASE TO TRADEMARKS
- 31 Jan 2012 — OPPOSITION TERMINATED NO. 999999